Related Topics News -

     
 Detail   |   Print    Next page > 
     
三葉草生物啟動呼吸道聯合疫苗候選產品I期臨床試驗
2025-06-17T  
三葉草生物與國光生技終止流感疫苗分銷合作
2025-06-16T  
三葉草生物附屬遭追討2.24億美元
2025-06-09T  
《業績》三葉草生物全年虧損擴大至9.03億人幣 核數師發表意見
2025-04-01T  
三葉草生物RSV候選疫苗美國臨床申報獲批
2025-03-24T  
三葉草生物附屬被索償2.24億美元預付款項
2025-03-24T  
三葉草生物二價RSV候選疫苗與GSKRSV疫苗頭對頭比較 在老年人受試者中獲積極臨床數據
2024-10-29T  
《業績》三葉草生物半年盈轉虧蝕9,512.3萬人幣
2024-08-28T  
三葉草生物二價RSV候選疫苗I期臨床試驗 老年人群組獲積極初步數據
2024-06-18T  
三葉草生物-B二價RSV候選疫苗I期臨床試驗獲積極初步數據
2024-04-08T  
  Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.